学术搜索 · AI 审稿 · LaTeX 协作

Menuka Karki

机构：The University of Texas MD Anderson Cancer Center, Harvard Stem Cell Institute · ORCID：0000-0002-1234-0024

发表论文 105 篇 · 总被引 590 次 · h-index 12

代表论文

Supplementary Table S8 from Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma (2026)
Supplementary Appendix S1 from Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma (2026)
Supplementary Table S3 from Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma (2026)
Supplementary Figure S4 from Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma (2026)
Supplementary File S1 from Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma (2026)
Supplementary Table S7 from Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma (2026)